Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Disulfiram plus Copper in Metastatic Breast Cancer
2024-514665-19-00Phase 2Completed
- Sponsor
- Palacky University Olomouc
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of disulfiram in breast cancer, sponsored by Palacky University Olomouc. Primary endpoints: Clinical response rate (RR) and Clinical benefit rate (CBR). Started Sep 2024; status: completed.
02
Drugs
disulfiram
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2024-514665-19-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514665-19-00.